SCHEMBL7470944

SCHEMBL7470944

COC1=CCc2cnc(Nc3ccc(N4CCN(CC=O)CC4)cc3)nc2C1C1CCCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 14/20 0.42
AURKA O14965 2/20 0.42
CCND1 P24385 12/20 0.41
FGFR4 P22455 2/20 0.41
CCNE1 P24864 8/20 0.41
CDK2 P24941 8/20 0.41
CDK1 P06493 5/20 0.40
CCNB1 P14635 4/20 0.40
CCND2 P30279 4/20 0.40
CCND3 P30281 4/20 0.40
CCNE2 O96020 3/20 0.40
CCNA2 P20248 2/20 0.40
CCNA1 P78396 2/20 0.40
PAK4 O96013 1/20 0.40
PAK1 Q13153 1/20 0.40
PKN1 Q16512 1/20 0.40
ERBB3 P21860 1/20 0.40
SYK P43405 1/20 0.40
CCNB2 O95067 1/20 0.40
FGFR1 P11362 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7465044 0.92 CDK4 (0.45) CDK4AURKACCND1FGFR4CCNE1
SCHEMBL6087039 0.88 CDK4 (0.52) CDK4AURKACCND1FGFR4CCNE1
SCHEMBL7469937 0.88 CDK4 (0.41) CDK4AURKACCND1FGFR4CCNE1
SCHEMBL7476134 0.86 CDK4 (0.40) CDK4AURKACCND1FGFR4CCNE1
SCHEMBL7463602 0.85 CDK4 (0.38) CDK4AURKACCND1FGFR4CCNE1
SCHEMBL7472695 0.85 EGFR (0.42) CDK4AURKACCND1FGFR4CCNE1
SCHEMBL6087275 0.85 CDK4 (0.57) CDK4CCND1CCNE1CDK2CCND2
SCHEMBL6090448 0.85 CDK4 (0.54) CDK4CCND1FGFR4CCNE1CDK2
SCHEMBL6088226 0.85 SYK (0.52) CDK4CCND1CCNE1CDK2CDK1
SCHEMBL6087644 0.84 CDK4 (0.59) CDK4CCND1CCNE1CDK2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1235815-A1 QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES WARNER-LAMBERT COMPANY (US) 2002-09-04 EP claimed
WO-2001038315-A1 QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES WARNER-LAMBERT COMPANY (US) 2001-05-31 WO claimed
EP-1235815-A1 QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES WARNER-LAMBERT COMPANY (US) 2002-09-04 EP disclosed
WO-2001038315-A1 QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES WARNER-LAMBERT COMPANY (US) 2001-05-31 WO disclosed